Vir Biotechnology, Inc. (NASDAQ:VIR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Nelsen Other companies: City Therapeutics, Inc. (Board Director · Since at least Oct 19, 2026); Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Revolution Healthcare Acquisition Corp (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Mar 31, 2021 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Apr 13, 2021 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 18, 2020 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 2, 2021 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 8, 2017 · Past); Bellerophon Therapeutics Inc (Director · Feb 12, 2015 – Feb 13, 2015 · Past); Juno Therapeutics Inc (Director · Dec 18, 2014 – Mar 5, 2018 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Nov 9, 2015 · Past); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Oct 4, 2013 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Mar 3, 2017 · Past); Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Aug 14, 2014 · Past); NeurogesX Inc (Director · May 1, 2007 – Jun 7, 2012 · Past); Adolor Corp (Director · May 18, 2006 – May 17, 2007 · Past) | Director · Oct 10, 2019 – May 30, 2024 · Past |
| Kristina Burow Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Metacrine Inc (Director · Sep 15, 2020 – May 24, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Jun 6, 2023 · Past); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past) | Director · Oct 10, 2019 – May 21, 2020 · Past |
| Robert J Perez Other companies: Rapport Therapeutics, Inc. (Director · Since at least Nov 7, 2024); Immunocore Holdings plc (Director · Jan 2, 2024 – Jan 2, 2024 · Past); Third Harmonic Bio Inc. (Director · Sep 14, 2022 – Mar 6, 2023 · Past); Cogent Biosciences, Inc. (Director · Mar 28, 2018 – Jun 14, 2019 · Past); Spark Therapeutics Inc (Director · Jan 3, 2018 – Dec 17, 2019 · Past); Larimar Therapeutics, Inc. (Director · Sep 24, 2015 – Jun 26, 2019 · Past); Decoy Therapeutics Inc. (Director · Sep 2, 2015 – Jul 26, 2017 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 22, 2017 · Past); AMAG Pharmaceuticals Inc (Director · Jan 26, 2009 – May 16, 2019 · Past); Cubist Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past) | Director · Oct 10, 2019 – May 22, 2023 · Past |
| Vicki Sato Other companies: Allogene Therapeutics, Inc. (Director · Since at least Jul 30, 2021); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jan 2, 2025 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 11, 2019 · Past); BorgWarner Inc. (Director · Feb 12, 2014 – Apr 29, 2020 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2007 – Jun 2, 2010 · Past); Bristol-Myers Squibb Company (Director · Jul 11, 2006 – Feb 1, 2021 · Past); Revvity, Inc. (Director · May 2, 2006 – Feb 9, 2017 · Past) | Director · Since at least Oct 10, 2019 |
| Saira Ramasastry Other companies: Sensei Biotherapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 15, 2026); Mirum Pharmaceuticals, Inc. (Director · Since at least Jun 2, 2022); Day One Biopharmaceuticals Inc (Director · Since at least May 26, 2021); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Repros Therapeutics (Director · Mar 25, 2013 – Jan 29, 2018 · Past); Filana Therapeutics, Inc. (Director · Feb 11, 2013 – Dec 13, 2019 · Past); Sangamo Therapeutics, Inc. (Director · Jun 21, 2012 – Feb 25, 2022 · Past) | Director · Since at least Oct 10, 2019 |
| Dipchand Nishar Other companies: Seer, Inc. (Director · Since at least Feb 13, 2021); Senti Biosciences Holdings, Inc. (Director · May 25, 2021 – May 25, 2021 · Past); Relay Therapeutics, Inc. (Director · Jul 15, 2020 – Jul 15, 2020 · Past); Guardant Health, Inc. (Director · Oct 3, 2018 – May 18, 2020 · Past); TripAdvisor, Inc. (Director · Sep 5, 2013 – Jun 21, 2019 · Past); LinkedIn Corp (SVP, Products, User Experience · May 18, 2011 – Sep 2, 2014 · Past) | Director · Oct 10, 2019 – May 21, 2021 · Past |
| Jeffrey S. Hatfield Other companies: Larimar Therapeutics, Inc. (Chief Executive Officer, Director · Oct 9, 2017 – Jan 22, 2019 · Past); Viridian Therapeutics, Inc. (Director · Aug 10, 2017 – Feb 4, 2021 · Past); aTyr Pharma, Inc. (Director · Apr 3, 2017 – May 6, 2020 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 1, 2016 – Jan 19, 2018 · Past); Vitae Pharmaceuticals Inc (Chief Executive Officer, Director · Sep 24, 2014 – Oct 24, 2016 · Past); Ambit Biosciences Corp (Director · Jun 2, 2014 – Nov 10, 2014 · Past) | Chair of the Board · Since at least Dec 9, 2020 |
| Michael E Kamarck Other companies: Passage Bio, Inc. (Director · Jul 2, 2022 – May 25, 2023 · Past); Vaxcyte, Inc. (Director · Oct 27, 2021 – Jun 13, 2023 · Past); Trillium Therapeutics Inc (Director · Jan 1, 2021 – Nov 17, 2021 · Past); Unilife Corp (Director · Jul 28, 2016 – Jul 28, 2016 · Past); Omni Bio Pharmaceutical Inc (Director · Jan 31, 2013 – Jan 31, 2013 · Past) | Chief Technology Officer · Oct 10, 2019 – Oct 10, 2019 · Past |
| Timothy P. Coughlin Other companies: ADC Therapeutics SA (Director · Since at least Jun 3, 2025); aTyr Pharma, Inc. (Chairman · Since at least Apr 7, 2017); Travere Therapeutics, Inc. (Director · Since at least Mar 31, 2015); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Jun 7, 2024 · Past); Neurocrine Biosciences, Inc. (Chief Financial Officer · Sep 18, 2006 – Feb 6, 2017 · Past) | Director · Since Jun 9, 2026 |
| George Scangos Other companies: Voyager Therapeutics, Inc. (Director · Since at least May 9, 2023); Agilent Technologies, Inc. (Director · Since at least Mar 16, 2017); Exelixis, Inc. (Director · May 26, 2016 – May 18, 2020 · Past); Biogen Inc. (Chief Executive Officer, Director · Apr 1, 2016 – Jul 21, 2016 · Past) | Director · Oct 10, 2019 – Feb 24, 2025 · Past |
| Charles Elliott Sigal Other companies: Alnylam Pharmaceuticals, Inc. (Director · Since at least Aug 22, 2022); Surface Oncology Inc (Director · Apr 18, 2018 – Sep 8, 2023 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 3, 2023 · Past) | Director · Since at least Jul 10, 2020 |
| Mark Eisner Other companies: Jade Biosciences, Inc. (Director · Since at least Jun 25, 2026); Zura Bio Limited (Director · Since at least Feb 21, 2026); Kyntra Bio, Inc. (EVP, Chief Medical Officer · Dec 1, 2020 – Sep 6, 2023 · Past) | EVP and Chief Medical Officer · Since at least Jun 3, 2024 |
| Norbert Bischofberger Other companies: Kronos Bio Inc (Director · Since at least Oct 8, 2020); Morphic Holding Inc (Director · Jun 26, 2019 – Aug 16, 2024 · Past); Gilead Sciences, Inc. (EVP, R&D and CSO · Jan 25, 2006 – Feb 15, 2018 · Past) | Director · Since at least May 29, 2024 |
| Phillip A Sharp Other companies: Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 1, 2022 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 1, 2006 – Jan 23, 2025 · Past); Biogen Inc. (Director · Jan 9, 2006 – Jun 3, 2009 · Past) | Director · Oct 10, 2019 – May 22, 2023 · Past |
| Sung Lee Other companies: Tango Therapeutics, Inc. (Executive Vice President and Chief Financial Officer, Cytokinetics · Since at least Jan 2, 2026); Cytokinetics, Incorporated (EVP, Chief Financial Officer · Since at least Apr 26, 2024); Sangamo Therapeutics, Inc. (EVP, Chief Financial Officer · Oct 31, 2019 – Nov 25, 2020 · Past) | EVP & Chief Financial Officer · Mar 27, 2023 – Mar 27, 2024 · Past |
| Janet Napolitano Other companies: Fortinet, Inc. (Director · Since at least Nov 7, 2024); Zoom Communications, Inc. (Director · Since at least Nov 2, 2020) | Director · Since at least Aug 28, 2020 |
| Jason V. O'Byrne Other companies: Olema Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Aug 11, 2026); Caribou Biosciences, Inc. (Chief Financial Officer · Jul 22, 2021 – Feb 20, 2024 · Past) | EVP & Chief Financial Officer · Since at least Oct 2, 2024 |
| Marianne De Backer Other companies: Kronos Bio Inc (Director · Jan 25, 2021 – Jun 22, 2023 · Past); Arrowhead Pharmaceuticals, Inc. (Director · Dec 12, 2019 – Jan 10, 2023 · Past) | PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR · Since at least Apr 3, 2023 |
| Ramy Farid Other companies: Schrodinger, Inc. (President and CEO, Board Member · Since at least Feb 5, 2020); Structure Therapeutics, Inc. (Director · Feb 2, 2023 – Feb 7, 2023 · Past) | Director · Since at least May 29, 2024 |
| Robert More Other companies: Tyra Biosciences, Inc. (Board Member · Since at least Sep 14, 2021); Glaukos Corporation (Director · Jun 24, 2015 – Jun 30, 2015 · Past) | Director · Since at least Oct 10, 2019 |
| Aziz Sawaf Other companies: Theravance Biopharma, Inc. (SVP & CHIEF FINANCIAL OFFICER · Since at least Jan 1, 2023) | EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICer · Since at least Oct 1, 2026 |
| Elliott Sigal Other companies: Alnylam Pharmaceuticals, Inc. (Director · Since at least Nov 4, 2026) | Director · Since at least Nov 5, 2026 |
| Howard Horn Other companies: Ultragenyx Pharmaceutical Inc. (Chief Financial Officer · Since at least Oct 9, 2023) | CFO · Oct 10, 2019 – Feb 23, 2023 · Past |
| Johanna Friedl-Naderer Other companies: Dyne Therapeutics, Inc. (Chief Commercial Officer · Since at least Sep 3, 2024) | EVP & Chief Operating Officer · Mar 2, 2022 – Mar 3, 2023 · Past |
| Ann M Hanly | EVP & Chief Technology Officer · Mar 29, 2021 – Feb 24, 2025 · Past |
| Arran Attridge | Senior Vice President, Corporate Communications · Mar 13, 2025 – Nov 4, 2026 · Past |
| Brent Sabatini | Interim Principal Financial Officer · Since at least Oct 1, 2024 |
| Carolyn Wang | SENIOR VICE PRESIDENT CORPORATE COMMUNICATIONS · Since at least Nov 5, 2026 |
| David Liu | EXECUTIVE VICE PRESIDENT AND CHIEF MEDICAL OFFICER · Since at least Oct 7, 2026 |
| Herbert Virgin | EVP, Research & CSO · Oct 10, 2019 – Aug 9, 2022 · Past |
| InvestorsNeera Ravindran | MDHead of Investor Relations & Strategic · Since at least Feb 23, 2026 |
| Jay Parrish | Chief Business Officer · Oct 10, 2019 – Apr 1, 2021 · Past |
| Jeff Calcagno | Executive Vice President and Chief Business Officer · Since at least Nov 4, 2026 |
| Jennifer Eileen Towne | Executive Vice President and Chief Scientific Officer · Since at least Nov 5, 2026 |
| Kiki Patel | PharmDHead of Investor Relations · Since at least Nov 2, 2026 |
| Klaus Frueh | Director · Oct 10, 2019 – Oct 16, 2019 · Past |
| Maninder Hora | EXECUTIVE VICE PRESIDENT AND CHIEF TECHNICAL OPERATIONS OFFICER · Since at least Feb 26, 2025 |
| Phillip Pang | EVP & Chief Medical Officer · Oct 10, 2019 – Feb 22, 2024 · Past |
| Richard Lepke | Senior Director, Investor Relations · Oct 9, 2025 – Nov 4, 2026 · Past |
| Steven J Rice | Chief Administrative Officer · Jul 30, 2020 – Jun 1, 2023 · Past |
| Suzanne Topalian | Director · Since at least Oct 27, 2026 |
| Toby Medaris | EXECUTIVE VICE PRESIDENT AND CHIEF HUMAN RESOURCES OFFICER · Since at least Nov 4, 2026 |
| Vanina de Verneuil | Executive Vice President General Counsel and Corporate Secretary · Since at least Oct 1, 2024 |